Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.57 |
| ▸ | HPGD | P15428 | 5/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.57 |
| ▸ | TP53 | P04637 | 4/20 | 0.57 |
| ▸ | TSHR | P16473 | 3/20 | 0.57 |
| ▸ | CASP1 | P29466 | 3/20 | 0.57 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.57 |
| ▸ | CASP7 | P55210 | 2/20 | 0.57 |
| ▸ | GSK3B | P49841 | 1/20 | 0.41 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.41 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | NQO2 | P16083 | 1/20 | 0.40 |
| ▸ | AHR | P35869 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 4/20 | 0.37 |
| ▸ | RAB9A | P51151 | 3/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21187695 | 0.87 | ALDH1A1 (0.44) | ALDH1A1HSD17B10HPGDMAPK1TP53 | |
| SCHEMBL732391 | 0.86 | ALDH1A1 (0.44) | ALDH1A1HSD17B10HPGDMAPK1TP53 | |
| SCHEMBL21187676 | 0.79 | HSD17B10 (0.34) | ALDH1A1HSD17B10HPGDMAPK1TP53 | |
| SCHEMBL21187699 | 0.79 | TLR8 (0.38) | ALDH1A1HSD17B10HPGDMAPK1TP53 | |
| SCHEMBL22798938 | 0.78 | NPC1 (0.38) | ALDH1A1HSD17B10HPGDMAPK1TP53 | |
| SCHEMBL2512112 | 0.77 | PTPRC (0.42) | MAPK1GSK3BCYP1A2SMN1; SMN2 | |
| SCHEMBL13309041 | 0.76 | ALDH1A1 (0.36) | ALDH1A1HSD17B10HPGDMAPK1TP53 | |
| SCHEMBL29827450 | 0.76 | PABPC1 (0.55) | ALDH1A1HSD17B10MAPK1TP53TSHR | |
| SCHEMBL13854906 | 0.76 | ALDH1A1 (0.55) | ALDH1A1HSD17B10HPGDMAPK1TP53 | |
| SCHEMBL458586 | 0.76 | PABPC1 (0.55) | ALDH1A1HSD17B10MAPK1TP53TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160093809-A1 | ORGANIC LIGHT EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2016-03-31 | — | — | US | disclosed |
| US-20160093809-A1 | ORGANIC LIGHT EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2016-03-31 | — | — | US | disclosed |
| US-8072137-B2 | Fused heterocyclic compound and organic light emitting device | CANON KABUSHIKI KAISHA (JP) | 2011-12-06 | — | — | US | disclosed |
| US-8072137-B2 | Fused heterocyclic compound and organic light emitting device | CANON KABUSHIKI KAISHA (JP) | 2011-12-06 | — | — | US | disclosed |
| US-20090121625-A1 | FUSED HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2009-05-14 | — | — | US | disclosed |
| US-20090121625-A1 | FUSED HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2009-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090121625-A1 | FUSED HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE | TYR, CRY1, LAGE3 | ALDH1A1 145/4885HSD17B10 2689/4885HPGD 516/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.